Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns | NEJM

Null

Abstract Background Neonatal hypoxic–ischemic encephalopathy is an important cause of death as well as long-term disability in survivors. Erythropoietin has been hypothesized to have neuroprotective effects in infants with hypoxic–ischemic encephalopathy, but its effects on neurodevelopmental outcomes when given in conjunction with therapeutic hypothermia are unknown. Methods In a multicen...

Read Complete Article

Post a Comment

Previous Post Next Post